NK Cell responses to human tick-borne encephalitis virus infection

Journal of Immunology

Volumn 197, Issue 7, 2016, Pages 2762-2771

  Blom, Kim ^a   Braun, Monika ^a   Pakalniene, Jolita ^b   Lunemann, Sebastian ^a,c   Enqvist, Monika ^a   Dailidyte, Laura ^b   Schaffer, Marie ^c   Lindquist, Lars ^a   Mickiene, Aukse ^a,b   Michaëlsson, Jakob ^a   Ljunggren, Hans Gustaf ^a   Gredmark Russ, Sara ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CD56 ANTIGEN; CD57 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P70; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; KI 67 ANTIGEN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TUMOR NECROSIS FACTOR;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SYMPTOMATOLOGY; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS VIRUS; IMMUNOLOGY; VIROLOGY;

ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; HUMANS; KILLER CELLS, NATURAL;

EID: 84989915589     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600950     Document Type: Article

References (52)

1. Lindquist, L., and O. Vapalahti. 2008. Tick-borne encephalitis. Lancet 371: 1861-1871.
2. Haglund, M., and G. Gunther. 2003. Tick-borne encephalitis-pathogenesis, clinical course and long-Term follow-up. Vaccine 21(Suppl. 1): S11-S18.
3. Donoso Mantke, O., R. Schädler, and M. Niedrig. 2008. A survey on cases of tick-borne encephalitis in European countries. Euro Surveill. 13: 217-224.
4. Mansfield, K. L., N. Johnson, L. P. Phipps, J. R. Stephenson, A. R. Fooks, and T. Solomon. 2009. Tick-borne encephalitis virus -A review of an emerging zoonosis. J. Gen. Virol. 90: 1781-1794.
5. Gelpi, E., M. Preusser, F. Garzuly, H. Holzmann, F. X. Heinz, and H. Budka. 2005. Visualization of Central European tick-borne encephalitis infection in fatal human cases. J. Neuropathol. Exp. Neurol. 64: 506-512.
6. Gelpi, E., M. Preusser, U. Laggner, F. Garzuly, H. Holzmann, F. X. Heinz, and H. Budka. 2006. Inflammatory response in human tick-borne encephalitis: Analysis of postmortem brain tissue. J. Neurovirol. 12: 322-327.
7. Gunther, G., M. Haglund, L. Lindquist, B. Sköldenberg, and M. Forsgren. 1997. Intrathecal IgM, IgA and IgG antibody response in tick-borne encephalitis. Long-Term follow-up related to clinical course and outcome. Clin. Diagn. Virol. 8: 17-29.
8. Schwaiger, J., J. H. Aberle, K. Stiasny, B. Knapp, W. Schreiner, I. Fae, G. Fischer, O. Scheinost, V. Chmelik, and F. X. Heinz. 2014. Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction. J. Virol. 88: 7828-7842.
9. Blom, K., M. Braun, J. Pakalniene, L. Dailidyte, V. Béziat, M. H. Lampen, J. Klingström, N. Lagerqvist, T. Kjerstadius, J. Michaëlsson, et al. 2015. Specificity and dynamics of effector and memory CD8 T cell responses in human tick-borne encephalitis virus infection. PLoS Pathog. 11: e1004622.
10. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735.
11. Bryceson, Y. T., E. Rudd, C. Zheng, J. Edner, D. Ma, S. M. Wood, A. G. Bechensteen, J. J. Boelens, T. Celkan, R. A. Farah, et al. 2007. Defective cytotoxic lymphocyte degranulation in syntaxin-11 deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood 110: 1906-1915.
12. Orange, J. S. 2002. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 4: 1545-1558.
13. Jost, S., and M. Altfeld. 2013. Control of human viral infections by natural killer cells. Annu. Rev. Immunol. 31: 163-194.
14. Fauriat, C., E. O. Long, H. G. Ljunggren, and Y. T. Bryceson. 2010. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115: 2167-2176.
15. Azeredo, E. L., L. M. De Oliveira-Pinto, S. M. Zagne, D. I. Cerqueira, R. M. Nogueira, and C. F. Kubelka. 2006. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin. Exp. Immunol. 143: 345-356.
16. Petitdemange, C., N. Wauquier, H. Devilliers, H. Yssel, I. Mombo, M. Caron, D. Nkoghé, P. Debré, E. Leroy, and V. Vieillard. 2016. Longitudinal analysis of natural killer cells in dengue virus-infected patients in comparison to chikungunya and chikungunya/dengue virus-infected patients. PLoS Negl. Trop. Dis. 10: e0004499.
17. Strauss-Albee, D. M., J. Fukuyama, E. C. Liang, Y. Yao, J. A. Jarrell, A. L. Drake, J. Kinuthia, R. R. Montgomery, G. John-Stewart, S. Holmes, and C. A. Blish. 2015. Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility. Sci. Transl. Med. 7: 297ra115.
18. Larena, M., M. Regner, and M. Lobigs. 2013. Cytolytic effector pathways and IFN-g help protect against Japanese encephalitis. Eur. J. Immunol. 43: 1789- 1798.
19. Marquardt, N., M. A. Ivarsson, K. Blom, V. D. Gonzalez, M. Braun, K. Falconer, R. Gustafsson, A. Fogdell-Hahn, J. K. Sandberg, and J. Michaëlsson. 2015. The human NK cell response to yellow fever virus 17D is primarily governed by NK cell differentiation independently of NK cell education. J. Immunol. 195: 3262- 3272.
20. Nascimento Silva, J. R., L. A. Camacho, M. M. Siqueira, Mde. S. Freire, Y. P. Castro, Mde. L. Maia, A. M. Yamamura, R. M. Martins, and M de. L. Leal, Collaborative Group for the Study of Yellow Fever Vaccines. 2011. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella. Vaccine 29: 6327-6334.
21. Neves, P. C., D. C. Matos, R. Marcovistz, and R. Galler. 2009. TLR expression and NK cell activation after human yellow fever vaccination. Vaccine 27: 5543- 5549.
22. Wahid, S. F., S. Sanusi, M. M. Zawawi, and R. A. Ali. 2000. A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. Southeast Asian J. Trop. Med. Public Health 31: 259-263.
23. Green, S., S. Pichyangkul, D. W. Vaughn, S. Kalayanarooj, S. Nimmannitya, A. Nisalak, I. Kurane, A. L. Rothman, and F. A. Ennis. 1999. Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J. Infect. Dis. 180: 1429-1435.
24. Homchampa, P., S. Sarasombath, V. Suvatte, and M. Vongskul. 1988. Natural killer cells in dengue hemorrhagic fever/dengue shock syndrome. Asian Pac. J. Allergy Immunol. 6: 95-102.
25. Tomazic, J., and A. Ihan. 1997. Flow cytometric analysis of lymphocytes in cerebrospinal fluid in patients with tick-borne encephalitis. Acta Neurol. Scand. 95: 29-33.
26. Pirogova, N. P., V. V. Novitskii, O. V. Mikhailova, M. Y. Khlusova, L. V. Babaeva, O. V. Voronkova, A. P. Mel'nikova, M. R. Karpova, and L. V. Lukasheva. 2004. Cytogenetic disorders in peripheral blood lymphocytes of patients with febrile form of tick-borne encephalitis. Bull. Exp. Biol. Med. 137: 61-63.
27. Roederer, M., J. L. Nozzi, and M. C. Nason. 2011. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167- 174.
28. Palus, M., P. Formanová, J. Salát, E. Zampachová, J. Elsterová, and D. Ruzek. 2015. Analysis of serum levels of cytokines, chemokines, growth factors, and monoamine neurotransmitters in patients with tick-borne encephalitis: identification of novel inflammatory markers with implications for pathogenesis. J. Med. Virol. 87: 885-892.
29. Bihl, F., J. Pecheur, B. Bréart, G. Poupon, J. Cazareth, V. Julia, N. Glaichenhaus, and V. M. Braud. 2010. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J. Immunol. 185: 2174-2181.
30. Björkström, N. K., P. Riese, F. Heuts, S. Andersson, C. Fauriat, M. A. Ivarsson, A. T. Björklund, M. Flodström-Tullberg, J. Michaëlsson, M. E. Rottenberg, et al. 2010. Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood 116: 3853-3864.
31. Björkström, N. K., T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M. Evander, J. Michaëlsson, K. J. Malmberg, J. Klingström, C. Ahlm, and H. G. Ljunggren. 2011. Rapid expansion and long-Term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208: 13-21.
32. Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
33. Petitdemange, C., P. Becquart, N. Wauquier, V. Béziat, P. Debré, E. M. Leroy, and V. Vieillard. 2011. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog. 7: e1002268.
34. Hong, H. S., J. M. Eberhard, P. Keudel, B. A. Bollmann, M. Ballmaier, N. Bhatnagar, M. Zielinska-Skowronek, R. E. Schmidt, and D. Meyer-Olson. 2010. HIV infection is associated with a preferential decline in less-differentiated CD56dim CD16+ NK cells. J. Virol. 84: 1183-1188.
35. Lopez-Vergès, S., J. M. Milush, B. S. Schwartz, M. J. Pando, J. Jarjoura, V. A. York, J. P. Houchins, S. Miller, S. M. Kang, P. J. Norris, et al. 2011. Expansion of a unique CD57?NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108: 14725- 14732.
36. Gumá, M., C. Cabrera, I. Erkizia, M. Bofill, B. Clotet, L. Ruiz, and M. López- Botet. 2006. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 194: 38-41.
37. Björkström, N. K., A. Svensson, K. J. Malmberg, K. Eriksson, and H. G. Ljunggren. 2011. Characterization of natural killer cell phenotype and function during recurrent human HSV-2 infection. PLoS One 6: e27664.
38. Chijioke, O., A. Muller, R. Feederle, M. H. Barros, C. Krieg, V. Emmel, E. Marcenaro, C. S. Leung, O. Antsiferova, V. Landtwing, et al. 2013. Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. [Published erratum appears in 2015 Cell Reports 12: 901.] Cell Reports 5: 1489-1498.
39. Vargin, V. V., and B. F. Semenov. 1986. Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections. Acta Virol. 30: 303-308.
40. Blom, K., M. Braun, M. A. Ivarsson, V. D. Gonzalez, K. Falconer, M. Moll, H. G. Ljunggren, J. Michaëlsson, and J. K. Sandberg. 2013. Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector-To a memory-Type response. J. Immunol. 190: 2150-2158.
41. Horowitz, A., R. H. Behrens, L. Okell, A. R. Fooks, and E. M. Riley. 2010. NK cells as effectors of acquired immune responses: effector CD4+ T cell-dependent activation of NK cells following vaccination. J. Immunol. 185: 2808-2818.
42. Horowitz, A., K. C. Newman, J. H. Evans, D. S. Korbel, D. M. Davis, and E. M. Riley. 2010. Cross-Talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J. Immunol. 184: 6043-6052.
43. Larena, M., M. Regner, E. Lee, and M. Lobigs. 2011. Pivotal role of antibody and subsidiary contribution of CD8+ T cells to recovery from infection in a murine model of Japanese encephalitis. J. Virol. 85: 5446-5455.
44. Gaucher, D., R. Therrien, N. Kettaf, B. R. Angermann, G. Boucher, A. Filali- Mouhim, J. M. Moser, R. S. Mehta, D. R. Drake III, E. Castro, et al. 2008. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 205: 3119-3131.
45. Lobigs, M., A. Mullbacher, and M. Regner. 2003. MHC class I up-regulation by flaviviruses: Immune interaction with unknown advantage to host or pathogen. Immunol. Cell Biol. 81: 217-223.
46. Meresse, B., S. A. Curran, C. Ciszewski, G. Orbelyan, M. Setty, G. Bhagat, L. Lee, M. Tretiakova, C. Semrad, E. Kistner, et al. 2006. Reprogramming of CTLs into natural killer-like cells in celiac disease. J. Exp. Med. 203: 1343- 1355.
47. Béziat, V., L. L. Liu, J. A. Malmberg, M. A. Ivarsson, E. Sohlberg, A. T. Björklund, C. Retière, E. Sverremark-Ekström, J. Traherne, P. Ljungman, et al. 2013. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121: 2678-2688.
48. Ruzek, D., M. Vancová, M. Tesarová, A. Ahantarig, J. Kopecký, and L. Grubhoffer. 2009. Morphological changes in human neural cells following tick-borne encephalitis virus infection. J. Gen. Virol. 90: 1649-1658.
49. Tang, H., C. Hammack, S. C. Ogden, Z. Wen, X. Qian, Y. Li, B. Yao, J. Shin, F. Zhang, E. M. Lee, et al. 2016. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell 18: 587-590.
50. Ruzek, D., J. Salát, S. K. Singh, and J. Kopecký. 2011. Breakdown of the bloodbrain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cells. PLoS One 6: e20472.
51. Licon Luna, R. M., E. Lee, A. Mullbacher, R. V. Blanden, R. Langman, and M. Lobigs. 2002. Lack of both Fas ligand and perforin protects from flavivirusmediated encephalitis in mice. J. Virol. 76: 3202-3211.
52. Andersson, C. R., S. Vene, M. Insulander, L. Lindquist, A. Lundkvist, and G. Greunther. 2010. Vaccine failures after active immunisation against tick-borne encephalitis. Vaccine 28: 2827-2831.